FDA grants variance for Barco laser projector


The U.S. Food and Drug Administration granted a product variance for Barco’s new 6 primary laser 3D (6P) laser-illuminated projector. The FDA has also granted approval for a predefined laser show variance, allowing U.S.-based exhibitors to safely install the 4K Barco laser projector without excessive legal constraints and extra costs.

Exhibitors who install the Barco laser projector will not need to prove compliancy with the same stringent regulations as laser light shows. Thanks to its fully integrated and inherently safe design—featuring unified laser light sources that are housed within the projector—the Barco laser projector prevents direct contact with native laser light.

“By receiving a U.S. FDA product variance for our fully integrated laser-illuminated projector…we provide U.S. exhibitors hassle-free and worry-free installation of our projector, delivering true peace of mind,” commented Goran Stojmenovik, product manager for laser projection at Barco. “This is a great step in the right direction for laser-illuminated projection technology regulations worldwide.” Barco was one of the founding members of the Laser Illuminated Projector Association (LIPA) in 2011, striving for an internationally harmonized regulation and standard for laser-illuminated projection.

The Barco laser projector dramatically improves the 3D and general cinema experience.